These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18045196)

  • 1. Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison.
    Le Tourneau C; Raymond E; Faivre S
    Curr Pharm Des; 2007; 13(33):3427-39. PubMed ID: 18045196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies.
    Faivre S; Chièze S; Delbaldo C; Ady-Vago N; Guzman C; Lopez-Lazaro L; Lozahic S; Jimeno J; Pico F; Armand JP; Martin JA; Raymond E
    J Clin Oncol; 2005 Nov; 23(31):7871-80. PubMed ID: 16172454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
    Maroun JA; Belanger K; Seymour L; Matthews S; Roach J; Dionne J; Soulieres D; Stewart D; Goel R; Charpentier D; Goss G; Tomiak E; Yau J; Jimeno J; Chiritescu G;
    Ann Oncol; 2006 Sep; 17(9):1371-8. PubMed ID: 16966366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma.
    Le Tourneau C; Faivre S; Ciruelos E; Domínguez MJ; López-Martín JA; Izquierdo MA; Jimeno J; Raymond E
    Am J Clin Oncol; 2010 Apr; 33(2):132-6. PubMed ID: 19687728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
    Erba E; Bassano L; Di Liberti G; Muradore I; Chiorino G; Ubezio P; Vignati S; Codegoni A; Desiderio MA; Faircloth G; Jimeno J; D'Incalci M
    Br J Cancer; 2002 May; 86(9):1510-7. PubMed ID: 11986788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. comparison with the clinical results.
    Albella B; Faircloth G; López-Lázaro L; Guzmán C; Jimeno J; Bueren JA
    Eur J Cancer; 2002 Jul; 38(10):1395-404. PubMed ID: 12091072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.
    Geldof AA; Mastbergen SC; Henrar RE; Faircloth GT
    Cancer Chemother Pharmacol; 1999; 44(4):312-8. PubMed ID: 10447579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.
    Nuijen B; Bouma M; Henrar RE; Manada C; Bult A; Beijnen JH
    Anticancer Drugs; 1999 Nov; 10(10):879-87. PubMed ID: 10630355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines.
    Marchini S; Chiorino G; Faircloth GT; D'Incalci M
    J Biol Regul Homeost Agents; 2002; 16(3):241-8. PubMed ID: 12456028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.
    Nuijen B; Bouma M; Henrar RE; Floriano P; Jimeno JM; Talsma H; Kettenes-van den Bosch JJ; Heck AJ; Bult A; Beijnen JH
    PDA J Pharm Sci Technol; 2000; 54(3):193-208. PubMed ID: 10927911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.
    Broggini M; Marchini SV; Galliera E; Borsotti P; Taraboletti G; Erba E; Sironi M; Jimeno J; Faircloth GT; Giavazzi R; D'Incalci M
    Leukemia; 2003 Jan; 17(1):52-9. PubMed ID: 12529660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor compounds from tunicates.
    Rinehart KL
    Med Res Rev; 2000 Jan; 20(1):1-27. PubMed ID: 10608919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical armamentarium of marine-derived anti-cancer compounds.
    Jimeno JM
    Anticancer Drugs; 2002 May; 13 Suppl 1():S15-9. PubMed ID: 12173490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Gajate C; An F; Mollinedo F
    Clin Cancer Res; 2003 Apr; 9(4):1535-45. PubMed ID: 12684430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine organisms as a source of new anticancer agents.
    Schwartsmann G; Brondani da Rocha A; Berlinck RG; Jimeno J
    Lancet Oncol; 2001 Apr; 2(4):221-5. PubMed ID: 11905767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marine peptides and related compounds in clinical trial.
    Rawat DS; Joshi MC; Joshi P; Atheaya H
    Anticancer Agents Med Chem; 2006 Jan; 6(1):33-40. PubMed ID: 16475925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products in anticancer therapy.
    da Rocha AB; Lopes RM; Schwartsmann G
    Curr Opin Pharmacol; 2001 Aug; 1(4):364-9. PubMed ID: 11710734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications.
    Lee Y; Phat C; Hong SC
    Peptides; 2017 Sep; 95():94-105. PubMed ID: 28610952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature.
    Negi B; Kumar D; Rawat DS
    Curr Protein Pept Sci; 2017; 18(9):885-904. PubMed ID: 27455970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic activity of aplidine, a new agent of marine origin.
    Taraboletti G; Poli M; Dossi R; Manenti L; Borsotti P; Faircloth GT; Broggini M; D'Incalci M; Ribatti D; Giavazzi R
    Br J Cancer; 2004 Jun; 90(12):2418-24. PubMed ID: 15173857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.